Table 5.
Mortality.
| Mortality MSC (death/n) | Mortality in control (death/n) | Reason of death | Articles |
|---|---|---|---|
| 4/31 | NA | Complications of COVID-19 | 11 |
| 1/1 | NA | Septic shock after empyema | 13 |
| 1/12 | 7/12 |
MSC: acute respiratory failure Placebo: multiple organ failure (6) and respiratory failure (1) |
14 |
| 2/5 | NA |
Acute renal failure Cardiomyopathy and liver failure Bacterial pneumonia Complications of COVID-19 |
16 |
| 0/12 | 3/29 | Complications of COVID-19 | 18 |
| 2/16 | NA |
Bacterial pneumonia and septic shock Complications of COVID-19 |
21 |
| 2/9 | NA |
Multiple organ failure Respiratory arrest |
26 |
| 15/40 | 5/20 |
MSC: cardiopulmonary arrest (1) Multiple organ failure Not specified |
27 |
| 1/5 | 10/18 |
MSC: multiple organ failure Placebo: acute liver dysfunction (4); multiorgan failure (3); palliative care (2); cerebral bleeding (1) |
28 |
| 4/24 | NA | Complications of COVID-19 | 29 |
| 1/1 | NA | Multiple organ failure | 30 |
| 1/6 | 2/6 |
MSC: multiple organ failure Placebo: multiple organ failure and sepsis |
31 |
| 2/13 | NA |
Massive gastrointestinal bleeding due to a gastric ulcer Secondary fungal pneumonia |
32 |
| 5/20 | 4/10 | Not specified | 33 |
| 0/7 | 1/3 | Not specified | 34 |
| 5/11 | NA |
Multiple organ failure Cardiac arrest |
38 |
| 1/1 | NA | Lung transplant rejection | 63 |